Figures below are as of 21 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹0 |
| Estimated listing gain | +0.0% |
| Estimated listing price | ₹392 |
| Issue price | ₹392 |
| Issue size | ₹408.79 Cr |
| Subscription | 1.08x |
| Open date | 24 Mar 2026 |
| Close date | 27 Mar 2026 |
| Listing date | 02 Apr 2026 |
| Listing at | BSE, NSE |
| IPO type | Mainboard IPO |
| Registrar | Bigshare Services Pvt.Ltd. |
As of 21 Jul 2026, the grey market premium (GMP) for the Sai Parenteral's Ltd. IPO is ₹0, implying an estimated listing gain of about +0.0% and an estimated listing price near ₹392. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Sai Parenteral's Ltd. IPO is open for subscription from 24 Mar 2026 to 27 Mar 2026. It is expected to list on 02 Apr 2026.
The Sai Parenteral's Ltd. IPO is priced at ₹392 per share, with a total issue size of ₹408.79 Cr.
As of 21 Jul 2026, the Sai Parenteral's Ltd. IPO is subscribed 1.08x.